Xiaolong Ma

1.0k total citations
28 papers, 621 citations indexed

About

Xiaolong Ma is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaolong Ma has authored 28 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaolong Ma's work include Aortic aneurysm repair treatments (3 papers), Natural product bioactivities and synthesis (2 papers) and Cell death mechanisms and regulation (2 papers). Xiaolong Ma is often cited by papers focused on Aortic aneurysm repair treatments (3 papers), Natural product bioactivities and synthesis (2 papers) and Cell death mechanisms and regulation (2 papers). Xiaolong Ma collaborates with scholars based in China, United Kingdom and United States. Xiaolong Ma's co-authors include Juan Feng, Xinmin Zhou, Yifeng Yang, Haidan Liu, Qingbo Xu, Lulu Han, Juan Yang, Li Xie, Jiacheng Deng and Zhenkun Xia and has published in prestigious journals such as Circulation Research, Scientific Reports and The FASEB Journal.

In The Last Decade

Xiaolong Ma

28 papers receiving 613 citations

Peers

Xiaolong Ma
Xianghuai Lu United States
Yunpeng Xie China
Guanmei Wen China
Yonghong Shi China
Suihai Wang China
Boquan Wu China
Imtiaz A. Mawji Canada
Yanyang Wang China
Xianghuai Lu United States
Xiaolong Ma
Citations per year, relative to Xiaolong Ma Xiaolong Ma (= 1×) peers Xianghuai Lu

Countries citing papers authored by Xiaolong Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Ma more than expected).

Fields of papers citing papers by Xiaolong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Ma. The network helps show where Xiaolong Ma may publish in the future.

Co-authorship network of co-authors of Xiaolong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Ma. A scholar is included among the top collaborators of Xiaolong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Ma. Xiaolong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Na, Yan Feng, Chao Gu, et al.. (2025). Inflammatory markers predict efficacy of immunotherapy in advanced non-small cell lung cancer: a preliminary exploratory study. Discover Oncology. 16(1). 8–8. 3 indexed citations
2.
Ma, Xiaolong, et al.. (2024). Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways. Journal of Microbiology and Biotechnology. 34(12). 2637–2647. 5 indexed citations
3.
Cui, Xiuji, Xiaolong Ma, Na Liu, et al.. (2024). [Spatiotemporal distribution of newly diagnosed echinococcosis patients in Qinghai Province from 2016 to 2022].. PubMed. 36(5). 474–480. 1 indexed citations
4.
Ma, Xiaolong, Chun Li, Yang Zhao, et al.. (2023). B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis. Signal Transduction and Targeted Therapy. 8(1). 103–103. 28 indexed citations
5.
Jia, Yiting, Chenfeng Mao, Zihan Ma, et al.. (2022). PHB2 Maintains the Contractile Phenotype of VSMCs by Counteracting PKM2 Splicing. Circulation Research. 131(10). 807–824. 60 indexed citations
6.
Dang, Guohui, Tianrun Li, Guangxin Yang, et al.. (2022). T lymphocyte-derived extracellular vesicles aggravate abdominal aortic aneurysm by promoting macrophage lipid peroxidation and migration via pyruvate kinase muscle isozyme 2. Redox Biology. 50. 102257–102257. 42 indexed citations
7.
Han, Lulu, Yang Zhao, Xingzhong Zhang, et al.. (2021). The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Advances. 6(1). 46–61. 13 indexed citations
8.
9.
Zhao, Yang, Lulu Han, Xiaolong Ma, et al.. (2020). NSun2 regulates aneurysm formation by promoting autotaxin expression and T cell recruitment. Cellular and Molecular Life Sciences. 78(4). 1709–1727. 23 indexed citations
10.
Zhou, Huiling, Lijun Liu, Xiaolong Ma, et al.. (2020). RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage. Molecular and Cellular Biochemistry. 476(2). 1233–1243. 27 indexed citations
11.
Dang, Guohui, Jiacheng Deng, Huiying Liu, et al.. (2019). Shikonin attenuates hyperhomocysteinemia-induced CD4+ T cell inflammatory activation and atherosclerosis in ApoE−/− mice by metabolic suppression. Acta Pharmacologica Sinica. 41(1). 47–55. 35 indexed citations
12.
Yang, Juan, Guohui Dang, Huiying Liu, et al.. (2019). T‐cell–derived extracellular vesicles regulate B‐cell IgG production via pyruvate kinase muscle isozyme 2. The FASEB Journal. 33(11). 12780–12799. 20 indexed citations
13.
Ma, Xiaolong, et al.. (2019). Association of miR‑100 expression with clinicopathological features and prognosis of patients with lung cancer. Oncology Letters. 18(2). 1318–1322. 10 indexed citations
14.
Li, Wei, Xinfang Yu, Xiaolong Ma, et al.. (2018). Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway. Cellular Signalling. 50. 131–141. 43 indexed citations
15.
Wang, Yue, Xiaolong Ma, Yuxiang Wang, Yan Liu, & Congrong Liu. (2018). Comparison of Different Scoring Systems in the Assessment of Estrogen Receptor Status for Predicting Prognosis in Endometrial Cancer. International Journal of Gynecological Pathology. 38(2). 111–118. 4 indexed citations
16.
Yu, Xinfang, Wei Li, Zhenkun Xia, et al.. (2017). Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. BMC Cancer. 17(1). 449–449. 41 indexed citations
17.
Ma, Xiaolong, Chao Chen, Jennifer Veevers, et al.. (2017). CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method. Scientific Reports. 7(1). 42244–42244. 39 indexed citations
18.
Su, Jing, Wenjuan Yu, Jianying Liu, et al.. (2017). Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases. Pathology. 49(7). 740–749. 21 indexed citations
19.
Liu, Haidan, Wěi Li, Xinfang Yu, et al.. (2016). EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 7(35). 56338–56354. 38 indexed citations
20.
Liu, Haidan, Yunchang Yuan, Zhenkun Xia, et al.. (2014). Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells. BMC Cancer. 14(1). 98–98. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianghuai Lu Breakdown of academic impact, for papers by Yunpeng Xie Breakdown of academic impact, for papers by Guanmei Wen Breakdown of academic impact, for papers by Yonghong Shi Breakdown of academic impact, for papers by Suihai Wang Breakdown of academic impact, for papers by Boquan Wu Breakdown of academic impact, for papers by Imtiaz A. Mawji Breakdown of academic impact, for papers by Yanyang Wang
Rankless by CCL
2026